BillionaireNet
Oyler
John Oyler
Rank #2126
UNITED STATESHealthcareBiotech

John Oyler

Net Worth
$1.804B
+0.28% (24h)
John Oyler is the CEO and co-founder of BeOne Medicines. With a net worth of $2.0 billion, Oyler's journey in the biotech industry began after a career at McKinsey & Company and an MBA from Stanford. His career includes founding and selling several successful companies. A pivotal moment in his life was the loss of close friends to cancer, which fueled his commitment to developing affordable cancer treatments. Oyler's leadership has been instrumental in the growth of BeOne Medicines into a global enterprise, impacting the lives of over 1.7 million patients. He is an Entrepreneur Of The Year 2025 award winner, and continues to drive innovation in the oncology sector.

The Full Dossier

Early Life and Education

John V. Oyler was born in 1968 in Pittsburgh, Pennsylvania. He graduated from Massachusetts Institute of Technology (MIT) with a degree in mechanical engineering in 1990. He later earned an MBA from Stanford University.

Rise to Success

Oyler began his career as a consultant at McKinsey & Company. He later co-founded Telephia, a consumer telecom research firm, which was sold to The Nielsen Co. for $449 million in 2007. His next venture was BioDuro, a drug discovery outsourcing company, which he founded in 2005 and sold to PPD Inc. for $77 million in 2010. He co-founded BeOne Medicines in 2010 with Chinese biochemist Xiaodong Wang. Under his leadership, BeOne Medicines has developed cancer medicines and expanded into a global enterprise.

Key Business Strategies

Oyler's vision was to build a global biotechnology company with a focus on accelerating the development of cancer medicines and expanding access to these treatments. His strategies included securing partnerships with industry leaders, developing breakthrough cancer drugs, and establishing a strong presence in China.

Philanthropy

Information on Oyler's specific philanthropic initiatives and amounts was not found in the search results.

Career Timeline

2025

Entrepreneur Of The Year

Received Entrepreneur Of The Year 2025 Award

2018

BeOne Medicines listed in Hong Kong

Listed shares on the Hong Kong market.

2016

BeOne Medicines IPO

BeOne Medicines went public on the Nasdaq.

2010

Sold BioDuro

Sold BioDuro to PPD Inc.

2010

Founded BeOne Medicines

Co-founded BeOne Medicines, a biotechnology company.

2007

Sold Telephia

Telephia was sold to The Nielsen Co. for $449 million.

1998

Founded Telephia

Founded Telephia, a telecom research company.

1990

Graduated from MIT

Earned a degree in mechanical engineering.

Philanthropic Impact

Unknown$XB

Not Available

Information on specific philanthropy was not found in the search results.

Wealth Trajectory